← Open Payments lookup

ANJU GEEVARGHESE: Open Payments

NPI 1972002962 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$462 in 22 payments from 7 companies in 2025. Trend: 2023 $259 · 2024 $709 · 2025 $462

Food & beverage: $462
CompanyPaymentsAmount
Amgen Inc.10$173
Novo Nordisk Inc4$77
Cipher Pharmaceuticals US LLC1$73
Boehringer Ingelheim Pharmaceuticals, Inc.3$58
Lilly USA, LLC2$38
Bayer Healthcare Pharmaceuticals Inc.1$25
PFIZER INC.1$18

Products named: JARDIANCE, OTEZLA, Ozempic, Natroba, REPATHA, Kerendia, PREVNAR 20.

Industry payments across TX — which companies pay providers there.